Louise Frederika Kooij - 02 Jan 2025 Form 4 Insider Report for NewAmsterdam Pharma Co N.V. (NAMS)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NAMS	Option (right to buy)	Award	$0	+80,000		$0.000000	80,000	02 Jan 2025	Ordinary Shares	80,000	$25.96	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	25% of the shares underlying the option will vest on January 2, 2026, the one-year anniversary of vesting start date, with the remaining shares vesting in equal monthly installments thereafter for three years, subject to the Reporting Person's continued service through each such date.